These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1400942)

  • 1. Increased pregnancy failure rates after clomiphene following assisted reproductive technology.
    Saunders DM; Lancaster PA; Pedisich EL
    Hum Reprod; 1992 Sep; 7(8):1154-8. PubMed ID: 1400942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro fertilisation and gamete intrafallopian transfer: an integrative analysis of research, 1987-1992.
    Kenny DT
    Br J Obstet Gynaecol; 1995 Apr; 102(4):317-25. PubMed ID: 7612516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WITHDRAWN: Gonadotrophin-releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles.
    Daya S
    Cochrane Database Syst Rev; 2007 Jul; (1):CD001299. PubMed ID: 17636664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles.
    Daya S
    Cochrane Database Syst Rev; 2000; 2000(2):CD001299. PubMed ID: 10796763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of maternal age on clinical pregnancy and spontaneous abortion in women undergoing in vitro fertilization and gamete intra-fallopian transfer.
    Kenny DT
    Aust N Z J Obstet Gynaecol; 1994 Aug; 34(4):443-8. PubMed ID: 7848237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison among different ovarian stimulation regimens for assisted procreation procedures in patients with endometriosis.
    Chedid S; Camus M; Smitz J; Van Steirteghem AC; Devroey P
    Hum Reprod; 1995 Sep; 10(9):2406-11. PubMed ID: 8530675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
    Albuquerque LE; Saconato H; Maciel MC
    Cochrane Database Syst Rev; 2002; (3):CD002808. PubMed ID: 12137658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro fertilisation for unexplained subfertility.
    Pandian Z; Bhattacharya S; Nikolaou D; Vale L; Templeton A
    Cochrane Database Syst Rev; 2002; (2):CD003357. PubMed ID: 12076476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary down-regulation using leuprolide for the intensive ovulation management of poor prognosis patients having in vitro fertilization (IVF)-related treatments.
    Cummins JM; Yovich JM; Edirisinghe WR; Yovich JL
    J In Vitro Fert Embryo Transf; 1989 Dec; 6(6):345-52. PubMed ID: 2517507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The likelihood of pregnancy with IVF and GIFT in Australia and New Zealand.
    Kovacs GT
    Med J Aust; 1993 Jun; 158(12):805-7. PubMed ID: 8326888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of Buserelin to human menopausal gonadotrophins in patients with failed stimulations for IVF or GIFT.
    Smitz J; Devroey P; Camus M; Khan I; Staessen C; Van Waesberghe L; Wisanto A; Van Steirteghem AC
    Hum Reprod; 1988 Oct; 3 Suppl 2():35-8. PubMed ID: 3147990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertilization efficiency of morphologically abnormal spermatozoa in assisted reproduction is further impaired by antisperm antibodies on the male partner's sperm.
    Acosta AA; van der Merwe JP; Doncel G; Kruger TF; Sayilgan A; Franken DR; Kolm P
    Fertil Steril; 1994 Oct; 62(4):826-33. PubMed ID: 7926095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal progesterone as luteal phase support in an IVF/GIFT programme.
    Polson DW; Rogers PA; Krapez JA; Leeton JF
    Eur J Obstet Gynecol Reprod Biol; 1992 Aug; 46(1):35-8. PubMed ID: 1426499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility treatment in the forty and older woman.
    Auyeung A; Klein ME; Ratts VS; Odem RR; Williams DB
    J Assist Reprod Genet; 2001 Dec; 18(12):638-43. PubMed ID: 11808844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials.
    Hughes EG; Fedorkow DM; Daya S; Sagle MA; Van de Koppel P; Collins JA
    Fertil Steril; 1992 Nov; 58(5):888-96. PubMed ID: 1426372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early pregnancy wastage after gamete manipulation.
    Yovich JL; Matson PL
    Br J Obstet Gynaecol; 1988 Nov; 95(11):1120-7. PubMed ID: 3207641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy complications, obstetric risks, and neonatal outcome in singleton and twin pregnancies after GIFT and IVF.
    Ochsenkühn R; Strowitzki T; Gurtner M; Strauss A; Schulze A; Hepp H; Hillemanns P
    Arch Gynecol Obstet; 2003 Oct; 268(4):256-61. PubMed ID: 12904987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting pregnancy rates of in vitro fertilization and gamete intrafallopian transfer.
    Chang SY; Soong YK; Chang MY
    Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):806-11. PubMed ID: 2687434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of spontaneous abortion in clomiphene pregnancies.
    Dickey RP; Taylor SN; Curole DN; Rye PH; Pyrzak R
    Hum Reprod; 1996 Dec; 11(12):2623-8. PubMed ID: 9021363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro fertilization, gamete intrafallopian transfer and combined IVF-GIFT results: three-year experience at Chang Gung Memorial Hospital.
    Soong YK; Chang MY; Chang SY; Chang SD; Chen MH; Jou DS; Wang ML
    Taiwan Yi Xue Hui Za Zhi; 1989 Oct; 88(10):1023-31. PubMed ID: 2699491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.